# Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-of-cdk4-inhibition-against-sarcomas-depends-on-their-levels-of-cdk4-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marco Pérez,Sandra Muñoz-Galván,Manuel P. Jiménez-García,Juan Marín,Amancio Carnero |
| Citations | 62 |
| DOI | 10.18632/oncotarget.5829 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.oncotarget.com/article/5829/pdf/ |
| OpenAlex ID | https://openalex.org/W2187845981 |
| PMID | 26528855 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Marco Pérez](https://scholariq.org/researchers/marco-perez/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.